164 related articles for article (PubMed ID: 22698521)
1. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2.
Novak N; Mete N; Bussmann C; Maintz L; Bieber T; Akdis M; Zumkehr J; Jutel M; Akdis C
J Allergy Clin Immunol; 2012 Nov; 130(5):1153-1158.e2. PubMed ID: 22698521
[TBL] [Abstract][Full Text] [Related]
2. Short-term venom immunotherapy induces desensitization of FcεRI-mediated basophil response.
Čelesnik N; Vesel T; Rijavec M; Šilar M; Eržen R; Košnik M; Kloft Žitnik SE; Avčin T; Korošec P
Allergy; 2012 Dec; 67(12):1594-600. PubMed ID: 23066930
[TBL] [Abstract][Full Text] [Related]
3. Changes in intracellular cyclic adenosine monophosphate levels in peripheral blood leukocytes during immunotherapy with vespid venom.
Bauer C; Przybilla B; Eberlein B; Kolsouzidou S; Ruëff F
Ann Allergy Asthma Immunol; 2007 Mar; 98(3):281-5. PubMed ID: 17378261
[TBL] [Abstract][Full Text] [Related]
4. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils.
Jutel M; Müller UR; Fricker M; Rihs S; Pichler WJ; Dahinden C
Clin Exp Allergy; 1996 Oct; 26(10):1112-8. PubMed ID: 8911695
[TBL] [Abstract][Full Text] [Related]
5. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
6. Basophil sensitivity in patients not responding to venom immunotherapy.
Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P
Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492
[TBL] [Abstract][Full Text] [Related]
7. Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry.
Nullens S; Sabato V; Faber M; Leysen J; Bridts CH; De Clerck LS; Falcone FH; Maurer M; Ebo DG
Cytometry B Clin Cytom; 2013 May; 84(3):173-8. PubMed ID: 23450838
[TBL] [Abstract][Full Text] [Related]
8. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy.
Siegmund R; Vogelsang H; Machnik A; Herrmann D
J Allergy Clin Immunol; 2000 Dec; 106(6):1190-5. PubMed ID: 11112905
[TBL] [Abstract][Full Text] [Related]
9. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
[TBL] [Abstract][Full Text] [Related]
10. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.
Eržen R; Košnik M; Silar M; Korošec P
Allergy; 2012 Jun; 67(6):822-30. PubMed ID: 22469017
[TBL] [Abstract][Full Text] [Related]
11. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity of basophils predicts side-effects in venom immunotherapy.
Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
[TBL] [Abstract][Full Text] [Related]
13. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
[TBL] [Abstract][Full Text] [Related]
14. Human basophil chemotaxis and activation are regulated via the histamine H4 receptor.
Mommert S; Kleiner S; Gehring M; Eiz-Vesper B; Stark H; Gutzmer R; Werfel T; Raap U
Allergy; 2016 Sep; 71(9):1264-73. PubMed ID: 26948974
[TBL] [Abstract][Full Text] [Related]
15. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
[TBL] [Abstract][Full Text] [Related]
16. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immunotherapy to wasp and bee venom.
Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
Clin Exp Allergy; 2011 Sep; 41(9):1226-34. PubMed ID: 21729181
[TBL] [Abstract][Full Text] [Related]
18. P38 mitogen-activated protein kinase signal transduction in the diagnosis and follow up of immunotherapy of wasp venom allergy.
Verweij MM; De Knop KJ; Bridts CH; De Clerck LS; Stevens WJ; Ebo DG
Cytometry B Clin Cytom; 2010 Sep; 78(5):302-7. PubMed ID: 20533388
[TBL] [Abstract][Full Text] [Related]
19. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
Cichocka-Jarosz E; Dorynska A; Pietrzyk JJ; Spiewak R
Immunotherapy; 2011 Aug; 3(8):1013-7. PubMed ID: 21843104
[TBL] [Abstract][Full Text] [Related]
20. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
